SirolimusImmunosuppressive AgentsTacrolimusCyclosporineKidney TransplantationMycophenolic AcidCalcineurinGraft RejectionDrug SubstitutionTreatment OutcomeDrug Therapy, CombinationLymphangioleiomyomatosisAngiomyolipomaTOR Serine-Threonine KinasesGraft SurvivalTime FactorsLymphangiomyomaInjections, IntraocularDose-Response Relationship, DrugCoronary RestenosisLiver TransplantationChyleKidneyTransplantation, HomologousCreatinineFollow-Up StudiesDrug MonitoringPolyenesDrug-Eluting StentsDrug Administration ScheduleDrug-Related Side Effects and Adverse ReactionsAntibiotics, AntineoplasticCardiovascular AgentsAdministration, OralRetrospective StudiesDrug InteractionsDouble-Blind MethodProspective StudiesDrug ImplantsImmunosuppressionIslets of Langerhans TransplantationAzathioprineGlomerular Filtration RateStentsTubulin ModulatorsTransplantationFluorescence Polarization ImmunoassayPilot ProjectsThrombotic MicroangiopathiesClinical Trials as TopicAdrenal Cortex HormonesOxaloacetic AcidCoated Materials, BiocompatibleCitrus paradisiDrug Delivery SystemsPaclitaxelHeart TransplantationPolycystic Kidney, Autosomal DominantAcetic AnhydridesAntineoplastic AgentsAntilymphocyte SerumOral UlcerAntipsychotic AgentsPostoperative ComplicationsKidney Function TestsSteroidsUnrelated DonorsNeoplasmsRenal InsufficiencyBiopsyPrednisoloneTuberous SclerosisGlucocorticoidsAnalgesics, OpioidKetoconazolePerivascular Epithelioid Cell NeoplasmsRespiratory System AgentsBenzenesulfonatesRibosomal Protein S6 Kinases, 70-kDaPsychoses, Substance-InducedAntibodies, MonoclonalProteinuriaBiliary FistulaDrug CombinationsRecurrenceAnti-Inflammatory AgentsDrug CarriersCell ProliferationTransplantation ConditioningClinical AuditIntention to Treat AnalysisKidney DiseasesNauseaCytochrome P-450 CYP3ACoronary AngiographyRats, Sprague-DawleyOligomenorrheaLiving DonorsAbsorbable ImplantsMucorales